EP1870906A1 - Device for concentrating technetium-99m pertechnetate and method thereof - Google Patents
Device for concentrating technetium-99m pertechnetate and method thereof Download PDFInfo
- Publication number
- EP1870906A1 EP1870906A1 EP06012651A EP06012651A EP1870906A1 EP 1870906 A1 EP1870906 A1 EP 1870906A1 EP 06012651 A EP06012651 A EP 06012651A EP 06012651 A EP06012651 A EP 06012651A EP 1870906 A1 EP1870906 A1 EP 1870906A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- pipeline
- electromagnetic valve
- pertechnetate
- receiving flask
- container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G4/00—Radioactive sources
- G21G4/04—Radioactive sources other than neutron sources
- G21G4/06—Radioactive sources other than neutron sources characterised by constructional features
- G21G4/08—Radioactive sources other than neutron sources characterised by constructional features specially adapted for medical application
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/0005—Isotope delivery systems
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/001—Recovery of specific isotopes from irradiated targets
- G21G2001/0042—Technetium
Definitions
- the present invention relates to a device for concentrating radioactive materials and a method thereof, especially to a device for concentrating 99m Tc pertechnetate and a method thereof.
- 99 Mo/ 99m Tc generator has the features of convenience, safety and easy operation that lead to its popularity in clinical use. However, after being used for a period of time, the specific activity is too low to be applied in clinical tests. Therefore, the old generators need to be replaced after a period of time.
- Technetium-99m is one of the most important radioisotopes used for medical diagnostics. It's formed from the decay of Molybdenum-99 which has a half-life of 67 hours. The characteristics of short half life and 140keV gamma ray emission make 99m Tc as an ideal for SPECT in clinical nuclear medicine imaging procedures or detection of tumor cells, such as 99m Tc-MDP bone imaging, 99m Tc-methoxyisobutylisonitrile (MIBI) SPECT in the detection of breast cancer, 99m Tc myoview for myocardial imaging, 99m Tc-HMPAO and 99m Tc-ECD for SPECT imaging of cerebral blood flow, 99m Tc-MAG3 for renal function scintigraphy and 99m Tc-TRODAT-1 imaging for diagnosis of Parkinson's disease, and so on. These show the importance and the potential of this diagnostic nuclide- 99m Tc in nuclear medicine.
- Technetium-99m solution is obtained from 99 Mo/ 99m Tc generator. Firstly get Technetium-99m pertechnetate by elution of with 12 ml normal saline.
- the present invention reveals a concentration device for 99m Tc pertechnetate and method thereof that controls concentration process of the 99m Tc pertechnetate by means of automatic control program.
- the device consists of a concentration unit and a control unit.
- the 99m Tc pertechnetate is concentrated through a cation- exchange solid phase extraction chromatography column and an anion exchange column inside the concentration device and the activity of the 99m Tc pertechnetate inside a receiving flask is measured by a radiation measurement module of the control device that connects to a Geiger-Muller Counter.
- a weighting scale member of a signal measurement module is used to weight the receiving flask.
- the present invention includes a concentration device 10, a control device 40 and a central processing unit (CPU) 50.
- the concentration device 10 is for carrying out concentration reaction while the control device 40 is for automatic control of the concentration device 10 by means of the central processing unit 50 that executes the automatic control program to run certain procedures for concentrating the 99m Tc pertechnetate (technetium-99m pertechnetate). For example, the volume of the 99m Tc pertechnetate is reduced from 12ml to 1ml.
- the concentration device 10 in accordance with the present invention consists of a first container 12 for containing the 99m Tc pertechnetate that is obtained by elution with normal saline from the 99 Mo/ 99m Tc generator, a cation- exchange solid phase extraction chromatography column 14 that connects with the first container 12 by a first pipeline 15a and the first pipeline 15a having a first electromagnetic valve 16a, an anion exchange column 18 that connects with the cation- exchange solid phase extraction chromatography column 14 by a second pipeline 15b and the second pipeline 15b having a second electromagnetic valve 16b.
- a second container 20 is for containing normal saline solution and is connected with the second electromagnetic valve 16b by a third pipeline 15c.
- a receiving flask 2 connects with the anion exchange column 18 by a fourth pipeline 15d while the fourth pipeline 15d includes a third electromagnetic valve 16c.
- a weighting scale member 24 and a first Geiger-Muller Counter 26 are disposed under the receiving flask 22 for detecting and monitoring the weight as well as the activity of the 99m Tc pertechnetate therein.
- a waste bottle 28 is connected with the third electromagnetic valve 16c by a fifth pipeline 15e and a receiving flask 22 includes a first receiving flask and a second receiving flask.
- a motor 30 -a creeping motor disposed between the fourth pipeline 15d and the fifth pipeline 15e transports the 99m Tc pertechnetate or normal saline into the receiving flask 22 or the waste bottle 28.
- the cation- exchange solid phase extraction chromatography column 14 is a silver ion solid phase extraction chromatography column while the anion exchange column 18 is a SepPak anion exchange column. Lead is disposed around the first Geiger-Muller Counter 26 for warding off radioactive interference from the outside.
- a control device 40 of an embodiment in accordance with the present invention is composed of a radiation measurement module 42, a signal measurement module 44, and a signal control module 46.
- the radiation measurement module 42 is connected with the first Geiger-Muller Counter 26 while the signal measurement module 44 is joined with the weighting scale member 24.
- the signal control module 46 connects to the motor 30, the first electromagnetic valve 16a, the second electromagnetic valve 16b, and the third electromagnetic valve 16c.
- the radiation measurement module 42 detects activity of the concentrated 99m Tc pertechnetate inside the receiving flask 22.
- the signal measurement module 44 gets weight of the concentrated 99m Tc pertechnetate inside the receiving flask 22.
- the central processing unit (CPU) 50 includes a memory 52 for saving the automatic control program and connects to the control device 40.
- the central processing unit 50 executes the automatic control program.
- a flow chart of an embodiment of a method for concentrating 99m Tc pertechnetate in accordance with the present invention is disclosed.
- an automatic control program is executed by a central processing unit (CPU) 50 so as to drive a radiation measurement module 42, a signal measurement module 44, and a signal control module 46.
- CPU central processing unit
- step S20 initiate a motor 30, a first electromagnetic valve 16a, a second electromagnetic valve 16b, and a third electromagnetic valve 16c so that 99m Tc pertechnetate in a first container 12 is transported into a cation- exchange solid phase extraction chromatography column 14, an anion exchange column 18 and waste bottle 28 through a first pipeline 15a, a second pipeline 15b, a fourth pipeline 15d, and a fifth pipeline 15e.
- the first electromagnetic valve 16a is turned off and normal saline inside a second container 20 is sent into the anion exchange column 18 and a first receiving bottle.
- the radiation measurement module 42 works to monitor activity of the 99m Tc pertechnetate through a first Geiger-Muller Counter 26, as shown in step S40.
- step S50 run the signal measurement module 44 to weight the 99m Tc pertechnetate inside the first receiving flask by a weighting scale member 24 so as to check whether to interrupt the automatic control program or not.
- an embodiment in this figure is different from the embodiment in Fig. 1B is in that the cation- exchange solid phase extraction chromatography column 14 in Fig. 1B connects with a first pipeline 15a and a first electromagnetic valve 16a while the cation- exchange solid phase extraction chromatography column 14 in Fig. 3 further connects with a sixth pipeline 15f and a fourth electromagnetic valve 16d.
- the fourth electromagnetic valve 16d connects to a third container 32 that contains normal saline Before the concentration device 10 running concentration procedures, the cation- exchange solid phase extraction chromatography column 14 needs to be washed so as to avoid influence on solid phase extraction chromatography of the 99m Tc pertechnetate in the first container 12.
- the motor 30 transports normal saline in the third container 32 passing through the cation- exchange solid phase extraction chromatography column 14 for washing it and then through the anion exchange column 18, the fourth pipeline 15d, the fifth pipeline 15e and conveyed to the waste bottle 28.
- a method for concentrating 99m Tc pertechnetate in accordance with the present invention further includes a step S120-initiate the motor 30, the second electromagnetic valve 16b, the third electromagnetic valve 16c and the fourth electromagnetic valve 16d and wash the cation- exchange solid phase extraction chromatography column 14, as well as step S130-turn off the fourth electromagnetic valve 16d, turn on the first electromagnetic valve 16a and transport the 99m Tc pertechnetate.
- the difference between the embodiment in this figure and the embodiment in Fig. 1B is in that the anion exchange column 18 in Fig. 1B connects with a first electromagnetic valve 16a, a second electromagnetic valve 16b, a first pipeline 15a and a second pipeline 15b while the anion exchange column 18 in Fig. 5 further connects with a seventh pipeline 15g and a fifth electromagnetic valve 16e.
- the fifth electromagnetic valve 16e connects to a fourth container 34 for containing normal saline. Once the fifth electromagnetic valve 16e is turned on, the motor 30 transports normal saline in the fourth container 34 into the anion exchange column 18 for eluting it and then the eluant is sent to the fourth pipeline 15d and the second receiving flask.
- this embodiment includes a further step-elute the anion exchange column 18.
- a method for concentrating 99m Tc pertechnetate in accordance with the present invention further includes a step S260- elute the anion exchange column 18. Firstly replace the first receiving flask by the second receiving flask. Then turned off the second electromagnetic valve 16band initiate the fifth electromagnetic valve 16e. The normal saline inside the fourth container 34 elutes the anion exchange column 18 for being sampled by the second receiving flask.
- a film 36 is disposed on top of the receiving flask 22 while a second Geiger-Muller Counter 38 is arranged on bottom of the waste bottle 28.
- the film 36 of the concentration device 10 of the present invention is used to filter concentrated 99m Tc pertechnetate obtained from normal saline and the second Geiger-Muller Counter 38 is used for the radiation measurement module 42 of the control device 40 to detect activity of the solution inside the waste bottle 28. If the solution inside the waste bottle 28 still contains the required level of activity, it can be recycled and concentrated again for being applied to the next test so as to reduce the waste.
- the concentration device of the present invention can prolong service life of generators.
- a 99 Mo/ 99m Tc generator with activity of 200mCi(minicurie) as an example, after the first elution, it takes 24 hours to get the maximum activity 140 mCi. And the activity of Tc-99m reduces along with the decay of parent nuclide 99 Mo, as shown in Fig. 8 & Fig. 9.
- the 99 Mo/ 99m Tc generator is eluted again by 10ml normal saline in the second hour. Then specific activity of the obtained Tc-99m is 35mCi/10ml.
- Tc-99m The activity of above mentioned Tc-99m is not enough for clinical use on lots tests of nuclear medicine.
- Tc-99m MIBI(Carolite) sold by pharmaceutical company- Bristol-Myers Squibb requires radioactivity level of 25-150mCi/1-3ml.
- the activity of recently released dopamine transporter imaging agent ( 99m Tc TRODAT-1) is 6-8mCi/ml.
- the radioactivity of the 99 Mo/ 99m Tc generator is 200mCi, the radioactivity of the 99 Mo/ 99m Tc is only 33mCi for being eluted seven days. If the initial activity of the generator is 500mCi, the radioactivity of the 99 Mo/ 99m Tc at elapsed time of 11 days is only 30mCi. As for hospitals, the specific activity is too low for clinical use and it need to purchase new generators. However, the present invention makes the radioactivity of 99 Mo/ 99m Tc change from 30mCi/10ml to 30mCi/1ml. There is no need to replace old generators for preparation of radioisotopes. Furthermore, lifetime of each generator is extended at least 3 days.
- the present invention is advantageous to prepare radiopharmaceuticals in clinical use, not only extends lifetime of generators, but also reduces cost for preparing radiopharmaceuticals. Moreover, due to automation of the concentration device of the present invention, the present invention decreases exposure time to radioactive material and further reduces the radiation dose to the operators. The present invention can also be applied to deal with concentration for Re-188 radioactive solution.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- High Energy & Nuclear Physics (AREA)
- Nuclear Medicine (AREA)
Abstract
Description
- The present invention relates to a device for concentrating radioactive materials and a method thereof, especially to a device for concentrating 99mTc pertechnetate and a method thereof.
- According to statistics made by Tzen, Kai-Yuan, director of nuclear medicine department, National Taiwan University Hospital on 2003, there are totally 88 SPECT (Single photon emission computed tomography) machines in nuclear medicine department of 43 hospitals in Taiwan. SPECT has been applied mainly to many fields of disease diagnosis, especially myocardial perfusion imaging and bone scan and the radioactive nuclide being mostly used is 99mTc. The result of this study is similar with the result of foreign studies. Taking data of American in 2002 as an example, the tests using radionucleotide 99mTc is as high as eleven million and fifty nine hundred thousand times, which occupied 80.9 percent of the entire tests. The data shows the importance of 99mTc in nuclear medicine.
- Besides nuclide characteristics, 99Mo/99mTc generator has the features of convenience, safety and easy operation that lead to its popularity in clinical use. However, after being used for a period of time, the specific activity is too low to be applied in clinical tests. Therefore, the old generators need to be replaced after a period of time.
- Technetium-99m is one of the most important radioisotopes used for medical diagnostics. It's formed from the decay of Molybdenum-99 which has a half-life of 67 hours. The characteristics of short half life and 140keV gamma ray emission make 99mTc as an ideal for SPECT in clinical nuclear medicine imaging procedures or detection of tumor cells, such as 99mTc-MDP bone imaging, 99mTc-methoxyisobutylisonitrile (MIBI) SPECT in the detection of breast cancer, 99mTc myoview for myocardial imaging, 99mTc-HMPAO and 99mTc-ECD for SPECT imaging of cerebral blood flow, 99mTc-MAG3 for renal function scintigraphy and 99mTc-TRODAT-1 imaging for diagnosis of Parkinson's disease, and so on. These show the importance and the potential of this diagnostic nuclide-99mTc in nuclear medicine.
- Technetium-99m solution is obtained from 99Mo/99mTc generator. Firstly get Technetium-99m pertechnetate by elution of with 12 ml normal saline.
- Then concentrate Technetium-99m pertechnetate by means of continuous bi-column solid chromatography, absorb Technetium-99m pertechnetate by anion exchange resin, and elute Technetium-99m pertechnetate by normal saline. Collect the eluant in different stages to manufacture Technetium-99m pertechnetate for medical use.
- Therefore it is a primary object of the present invention to provide a device for concentrating 99mTc pertechnetate and a method thereof that remotely monitors and in-time shows the reaction processing of condensation by automatic control so that the concentration quality and production efficiency of the 99mTc pertechnetate are improved.
- It is another primary object of the present invention to provide a concentration device for 99mTc pertechnetate and method thereof that makes reaction happen inside a close space so as to avoid exposure to radioactive material and reduce the radiation dose received by the operators. Since the radioactive nuclide enters the close system through pipelines for being condensed until the final products are output, the whole reaction is happened inside the close space.
- In order to achieve objects, the present invention reveals a concentration device for 99mTc pertechnetate and method thereof that controls concentration process of the 99mTc pertechnetate by means of automatic control program. The device consists of a concentration unit and a control unit. The 99mTc pertechnetate is concentrated through a cation-exchange solid phase extraction chromatography column and an anion exchange column inside the concentration device and the activity of the 99mTc pertechnetate inside a receiving flask is measured by a radiation measurement module of the control device that connects to a Geiger-Muller Counter. Moreover, a weighting scale member of a signal measurement module is used to weight the receiving flask.
- The structure and the technical means adopted by the present invention to achieve the above and other objects can be best understood by referring to the following detailed description of the preferred embodiments and the accompanying drawings, wherein
- Fig. 1A is a block diagram showing structure of an embodiment in accordance with the present invention;
- Fig. 1B is a block diagram showing a concentration device of an embodiment in accordance with the present invention;
- Fig. 1C is a block diagram showing a control device of an embodiment in accordance with the present invention;
- Fig. 1D is a block diagram showing a control device of an embodiment in accordance with the present invention;
- Fig. 2 is a flow chart showing concentration process of an embodiment in accordance with the present invention;
- Fig. 3 is a block diagram showing a concentration device of another embodiment in accordance with the present invention;
- Fig. 4 is a flow chart showing concentration process of another embodiment in accordance with the present invention;
- Fig. 5 is a block diagram showing a concentration device of a further embodiment in accordance with the present invention;
- Fig. 6 is a flow chart showing concentration process of a further embodiment in accordance with the present invention;
- Fig. 7 is a block diagram showing a concentration device of a further embodiment in accordance with the present invention;
- Fig. 8 is a schematic drawing showing measurement of Tc-99m activity vs time of a 99Mo/99mTC generator in accordance with the present invention;
- Fig. 9 is a schematic drawing showing measurement of 99Mo activity vs time of a 99Mo/9mTc generator in accordance with the present invention.
- Refer to Fig. 1A, the present invention includes a
concentration device 10, acontrol device 40 and a central processing unit (CPU) 50. Theconcentration device 10 is for carrying out concentration reaction while thecontrol device 40 is for automatic control of theconcentration device 10 by means of thecentral processing unit 50 that executes the automatic control program to run certain procedures for concentrating the 99mTc pertechnetate (technetium-99m pertechnetate). For example, the volume of the 99mTc pertechnetate is reduced from 12ml to 1ml. Refer to Fig. 1B, theconcentration device 10 in accordance with the present invention consists of afirst container 12 for containing the 99mTc pertechnetate that is obtained by elution with normal saline from the 99Mo/99mTc generator, a cation-exchange solid phaseextraction chromatography column 14 that connects with thefirst container 12 by afirst pipeline 15a and thefirst pipeline 15a having a firstelectromagnetic valve 16a, ananion exchange column 18 that connects with the cation-exchange solid phaseextraction chromatography column 14 by asecond pipeline 15b and thesecond pipeline 15b having a secondelectromagnetic valve 16b. - A
second container 20 is for containing normal saline solution and is connected with the secondelectromagnetic valve 16b by athird pipeline 15c. A receiving flask 2 connects with theanion exchange column 18 by afourth pipeline 15d while thefourth pipeline 15d includes a thirdelectromagnetic valve 16c. Aweighting scale member 24 and a first Geiger-Muller Counter 26 are disposed under the receivingflask 22 for detecting and monitoring the weight as well as the activity of the 99mTc pertechnetate therein. Furthermore, awaste bottle 28 is connected with the thirdelectromagnetic valve 16c by afifth pipeline 15e and a receivingflask 22 includes a first receiving flask and a second receiving flask. A motor 30 -a creeping motor disposed between thefourth pipeline 15d and thefifth pipeline 15e transports the 99mTc pertechnetate or normal saline into the receivingflask 22 or thewaste bottle 28. The cation-exchange solid phaseextraction chromatography column 14 is a silver ion solid phase extraction chromatography column while theanion exchange column 18 is a SepPak anion exchange column. Lead is disposed around the first Geiger-Muller Counter 26 for warding off radioactive interference from the outside. - Refer to Fig. 1C, a
control device 40 of an embodiment in accordance with the present invention is composed of aradiation measurement module 42, asignal measurement module 44, and asignal control module 46. Theradiation measurement module 42 is connected with the first Geiger-Muller Counter 26 while thesignal measurement module 44 is joined with theweighting scale member 24. And thesignal control module 46 connects to themotor 30, the firstelectromagnetic valve 16a, the secondelectromagnetic valve 16b, and the thirdelectromagnetic valve 16c. By the first Geiger-MullerCounter 26, theradiation measurement module 42 detects activity of the concentrated 99mTc pertechnetate inside the receivingflask 22. By theweighting scale member 24, thesignal measurement module 44 gets weight of the concentrated 99mTc pertechnetate inside the receivingflask 22. - Refer to Fig. ID, the central processing unit (CPU) 50 according to the present invention includes a
memory 52 for saving the automatic control program and connects to thecontrol device 40. Thecentral processing unit 50 executes the automatic control program. - Refer to Fig. 2, a flow chart of an embodiment of a method for concentrating 99mTc pertechnetate in accordance with the present invention is disclosed. Refer to step S10, an automatic control program is executed by a central processing unit (CPU) 50 so as to drive a
radiation measurement module 42, asignal measurement module 44, and asignal control module 46. In step S20, initiate amotor 30, a firstelectromagnetic valve 16a, a secondelectromagnetic valve 16b, and a thirdelectromagnetic valve 16c so that 99mTc pertechnetate in afirst container 12 is transported into a cation-exchange solid phaseextraction chromatography column 14, ananion exchange column 18 andwaste bottle 28 through afirst pipeline 15a, asecond pipeline 15b, afourth pipeline 15d, and afifth pipeline 15e. Refer to step S30, the firstelectromagnetic valve 16a is turned off and normal saline inside asecond container 20 is sent into theanion exchange column 18 and a first receiving bottle. Then theradiation measurement module 42 works to monitor activity of the 99mTc pertechnetate through a first Geiger-Muller Counter 26, as shown in step S40. In step S50, run thesignal measurement module 44 to weight the 99mTc pertechnetate inside the first receiving flask by aweighting scale member 24 so as to check whether to interrupt the automatic control program or not. - Refer to Fig. 3, an embodiment in this figure is different from the embodiment in Fig. 1B is in that the cation-exchange solid phase
extraction chromatography column 14 in Fig. 1B connects with afirst pipeline 15a and a firstelectromagnetic valve 16a while the cation-exchange solid phaseextraction chromatography column 14 in Fig. 3 further connects with asixth pipeline 15f and a fourthelectromagnetic valve 16d. The fourthelectromagnetic valve 16d connects to athird container 32 that contains normal saline Before theconcentration device 10 running concentration procedures, the cation-exchange solid phaseextraction chromatography column 14 needs to be washed so as to avoid influence on solid phase extraction chromatography of the 99mTc pertechnetate in thefirst container 12. Once the fourthelectromagnetic valve 16d is turned on, themotor 30 transports normal saline in thethird container 32 passing through the cation-exchange solid phaseextraction chromatography column 14 for washing it and then through theanion exchange column 18, thefourth pipeline 15d, thefifth pipeline 15e and conveyed to thewaste bottle 28. - Refer to Fig. 4, the difference between the flow chart of the embodiment in this figure and the embodiment in Fig. 2 is in that this embodiment includes a further step-washing the cation-exchange solid phase
extraction chromatography column 14. A method for concentrating 99mTc pertechnetate in accordance with the present invention further includes a step S120-initiate themotor 30, the secondelectromagnetic valve 16b, the thirdelectromagnetic valve 16c and the fourthelectromagnetic valve 16d and wash the cation-exchange solid phaseextraction chromatography column 14, as well as step S130-turn off the fourthelectromagnetic valve 16d, turn on the firstelectromagnetic valve 16a and transport the 99mTc pertechnetate. - Refer to Fig. 5, the difference between the embodiment in this figure and the embodiment in Fig. 1B is in that the
anion exchange column 18 in Fig. 1B connects with a firstelectromagnetic valve 16a, a secondelectromagnetic valve 16b, afirst pipeline 15a and asecond pipeline 15b while theanion exchange column 18 in Fig. 5 further connects with aseventh pipeline 15g and a fifthelectromagnetic valve 16e. The fifthelectromagnetic valve 16e connects to afourth container 34 for containing normal saline. Once the fifthelectromagnetic valve 16e is turned on, themotor 30 transports normal saline in thefourth container 34 into theanion exchange column 18 for eluting it and then the eluant is sent to thefourth pipeline 15d and the second receiving flask. - Refer to Fig. 6, the difference between the flow chart of the embodiment in this figure and the embodiment in Fig. 2 is in that this embodiment includes a further step-elute the
anion exchange column 18. A method for concentrating 99mTc pertechnetate in accordance with the present invention further includes a step S260- elute theanion exchange column 18. Firstly replace the first receiving flask by the second receiving flask. Then turned off the second electromagnetic valve 16band initiate the fifthelectromagnetic valve 16e. The normal saline inside thefourth container 34 elutes theanion exchange column 18 for being sampled by the second receiving flask. - Refer to Fig. 7, the difference between the embodiment in this figure and the embodiment in Fig. 1B is in that a
film 36 is disposed on top of the receivingflask 22 while a second Geiger-Muller Counter 38 is arranged on bottom of thewaste bottle 28. And thefilm 36 of theconcentration device 10 of the present invention is used to filter concentrated 99mTc pertechnetate obtained from normal saline and the second Geiger-Muller Counter 38 is used for theradiation measurement module 42 of thecontrol device 40 to detect activity of the solution inside thewaste bottle 28. If the solution inside thewaste bottle 28 still contains the required level of activity, it can be recycled and concentrated again for being applied to the next test so as to reduce the waste. - Therefore, it is learned that the concentration device of the present invention can prolong service life of generators. Take a 99Mo/99mTc generator with activity of 200mCi(minicurie) as an example, after the first elution, it takes 24 hours to get the
maximum activity 140 mCi. And the activity of Tc-99m reduces along with the decay of parent nuclide 99Mo, as shown in Fig. 8 & Fig. 9. After elution, the 99Mo/99mTc generator is eluted again by 10ml normal saline in the second hour. Then specific activity of the obtained Tc-99m is 35mCi/10ml. - The activity of above mentioned Tc-99m is not enough for clinical use on lots tests of nuclear medicine. For example, Tc-99m MIBI(Carolite) sold by pharmaceutical company- Bristol-Myers Squibb requires radioactivity level of 25-150mCi/1-3ml. The activity of recently released dopamine transporter imaging agent (99mTc TRODAT-1) is 6-8mCi/ml. By means of a concentration device according to the present invention, activity of the Tc-99m is not reduced while the volume is reduced into 1ml. Therefore, the efficiency of the 99Mo/99mTc generator is dramatically improved.
- Moreover, if the radioactivity of the 99Mo/99mTc generator is 200mCi, the radioactivity of the 99Mo/99mTc is only 33mCi for being eluted seven days. If the initial activity of the generator is 500mCi, the radioactivity of the 99Mo/99mTc at elapsed time of 11 days is only 30mCi. As for hospitals, the specific activity is too low for clinical use and it need to purchase new generators. However, the present invention makes the radioactivity of 99Mo/99mTc change from 30mCi/10ml to 30mCi/1ml. There is no need to replace old generators for preparation of radioisotopes. Furthermore, lifetime of each generator is extended at least 3 days.
- The present invention is advantageous to prepare radiopharmaceuticals in clinical use, not only extends lifetime of generators, but also reduces cost for preparing radiopharmaceuticals. Moreover, due to automation of the concentration device of the present invention, the present invention decreases exposure time to radioactive material and further reduces the radiation dose to the operators. The present invention can also be applied to deal with concentration for Re-188 radioactive solution.
- Additional advantages and modifications will readily occur to those skilled in the art. Therefore, the invention in its broader aspects is not limited to the specific details, and representative devices shown and described herein. Accordingly, various modifications may be made without departing from the spirit or scope of the general inventive concept as defined by the appended claims and their equivalents.
Claims (13)
- A device for concentrating 99mTc pertechnetate comprising:a concentration device that having :a first container for containing 99m Tc pertechnetate;a cation-exchange solid phase extraction chromatography column connecting with the first container by a first pipeline and the first pipeline having a first electromagnetic valve;an anion exchange column connecting with the cation-exchange solid phase extraction chromatography column by a second pipeline and the second pipeline having a second electromagnetic valve;a second container for containing normal saline solution connecting with the second electromagnetic valve by a third pipeline; anda receiving flask connecting with the anion exchange column by a fourth pipeline and the fourth pipeline having a third electromagnetic valve; a weighting scale member and a first Geiger-Muller Counter are disposed under the receiving flask for detecting and monitoring weight and activity of the 99mTc pertechnetate inside the receiving flask;a waste bottle connecting with the third electromagnetic valve by a fifth pipeline;wherein the 99mTc pertechnetate or normal saline is transported into the receiving flask or waste bottle of the first pipeline, the second pipeline, the third pipeline, the fourth pipeline, and the fifth pipeline;a control device having a radiation measurement module, a signal measurement module, and a signal control module; the radiation measurement module is connected with the first Geiger-Muller Counter and the signal measurement module is joined with the weighting scale member; the signal control module connects to the motor, the first electromagnetic valve, the second electromagnetic valve, and the third electromagnetic valve; anda central processing unit having a memory for saving an automatic control program and connecting to the control device;
wherein the automatic control program is executed by the central processing unit for control of weight and activity of the 99mTc pertechnetate inside the receiving flask so as to concentrate the 99mTc pertechnetate automatically. - The device as claimed in claim 1, wherein a second Geiger-Muller Counter that connects with the radiation measurement module is disposed under the waste bottle for monitoring the activity of the 99mTc pertechnetate inside the receiving flask.
- The device as claimed in claim 1, wherein a film is arranged on top of the receiving flask.
- The device as claimed in claim 1, wherein the motor is a creeping motor and is disposed between the fourth pipeline and the fifth pipeline.
- The device as claimed in claim 1, wherein the cation-exchange solid phase extraction chromatography column is a silver ion solid phase extraction chromatography column.
- The device as claimed in claim 1, wherein the anion exchange column is a SepPak anion exchange column.
- The device as claimed in claim 1, wherein the device further comprising a third container for containing sterilized water and the third container is connected with the cation-exchange solid phase extraction chromatography column through a sixth pipeline and a fourth electromagnetic valve.
- The device as claimed in claim 1, wherein the device further comprising a fourth container for containing normal saline and the fourth container is connected with the second pipeline through a seventh pipeline and a fifth electromagnetic valve.
- The device as claimed in claim 1, wherein lead is disposed around Lead is disposed around the first Geiger-Muller Counter and the second Geiger-Muller Counter for shielding radioactive interference from the outside.
- A method for concentrating 99mTc pertechnetate comprising the steps of:executing an automatic control program by a central processing unit so as to run a radiation measurement module, a signal measurement module, and a signal control module;running the signal control module having steps of:initiating a motor, a first electromagnetic valve, a second electromagnetic valve, and a third electromagnetic valve for transporting the 99mTc pertechnetate from the first container into a cation-exchange solid phase extraction chromatography column, an anion exchange column, and a waste bottle through a first pipeline, a second pipeline, a fourth pipeline, and a fifth pipeline; andturning off the first electromagnetic valve and transporting the normal saline into the anion exchange column and a first receiving flask;running the radiation measurement module through a first Geiger-Muller Counter to monitor activity; andrunning he signal measurement module to weight the 99mTc pertechnetate inside the first receiving flask through a weighting scale member so as to check whether to interrupt the automatic control program or not.
- The method as claimed in claim 10, wherein before the step of initiating a motor, a first electromagnetic valve, a second electromagnetic valve, and a third electromagnetic valve, the method further comprising a step of : initiating the motor, the second electromagnetic valve, the third electromagnetic valve and the fourth electromagnetic valve so as to transport sterilized water inside a third container into the waste bottle through a sixth pipeline, the second pipeline, the fourth pipeline, and the fifth pipeline.
- The method as claimed in claim 10, wherein after the step of turning off the first electromagnetic valve and transporting the normal saline into the anion exchange column and a first receiving flask, the method further comprising a step of :turning on a fifth electromagnetic valve for sending normal saline inside a fourth container into the anion exchange column through a seventh pipeline, and into a second receiving flask through the fourth pipeline.
- The method as claimed in claim 10, wherein when turning off the first electromagnetic valve and transporting the normal saline into the anion exchange column and a first receiving flask, the method further having a step of: running filtering process after the normal saline passing through the anion exchange column and receiving the normal saline being filtered by the first receiving flask.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20060012651 EP1870906B1 (en) | 2006-06-20 | 2006-06-20 | Device for concentrating technetium-99m pertechnetate and method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20060012651 EP1870906B1 (en) | 2006-06-20 | 2006-06-20 | Device for concentrating technetium-99m pertechnetate and method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1870906A1 true EP1870906A1 (en) | 2007-12-26 |
EP1870906B1 EP1870906B1 (en) | 2013-08-14 |
Family
ID=37198769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20060012651 Expired - Fee Related EP1870906B1 (en) | 2006-06-20 | 2006-06-20 | Device for concentrating technetium-99m pertechnetate and method thereof |
Country Status (1)
Country | Link |
---|---|
EP (1) | EP1870906B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102249352A (en) * | 2011-05-23 | 2011-11-23 | 中国工程物理研究院核物理与化学研究所 | Automatic production apparatus for medical pertechnetate |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4176158A (en) * | 1975-02-03 | 1979-11-27 | The Radiochemical Centre Ltd. | Process for concentrating technetium-99m |
US4778672A (en) * | 1985-11-27 | 1988-10-18 | University Of Cincinnati | Method of isolating radioactive perrhenate or pertechnetate from an aqueous solution |
WO1992020071A1 (en) * | 1991-05-01 | 1992-11-12 | Mallinckrodt Medical, Inc. | Method of conveying liquid materials and device for the automated elution of a radionuclide generator |
US20030127395A1 (en) * | 2001-06-22 | 2003-07-10 | Bond Andrew H. | Automated radionuclide separation system and method |
-
2006
- 2006-06-20 EP EP20060012651 patent/EP1870906B1/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4176158A (en) * | 1975-02-03 | 1979-11-27 | The Radiochemical Centre Ltd. | Process for concentrating technetium-99m |
US4778672A (en) * | 1985-11-27 | 1988-10-18 | University Of Cincinnati | Method of isolating radioactive perrhenate or pertechnetate from an aqueous solution |
WO1992020071A1 (en) * | 1991-05-01 | 1992-11-12 | Mallinckrodt Medical, Inc. | Method of conveying liquid materials and device for the automated elution of a radionuclide generator |
US20030127395A1 (en) * | 2001-06-22 | 2003-07-10 | Bond Andrew H. | Automated radionuclide separation system and method |
Non-Patent Citations (4)
Title |
---|
CHATTOPADHYAY ET AL.: "A novel <99m>Tc delivery system using (n,y)<99>Mo adsorbed on a large alumina column in tandem with Dovex-1 and AgCl columns", APPLIED RADIATION AND ISOTOPES, vol. 57, 2002, pages 7 - 16, XP002406119 * |
KNAPP ET AL.: "Use of a new tandem cation/anion exchange system with clinical-scale generators provides high specific volume solutions of Technetium-99m and Rhenium-188", PROC. INTERNATIONAL TRENDS IN RADIOPHARMACEUTICALS FOR DIAGNOSIS AND THERAPY, 1998, IAEA TECDOC-1029, pages 419 - 425, XP008071321 * |
MANSUR M S ET AL: "Concentration of <99m>Tc-pertechnetate and <188>Re-perrhenate", RADIOCHIMICA ACTA OLDENBOURG GERMANY, vol. 94, no. 2, February 2006 (2006-02-01), pages 107 - 111, XP008070999, ISSN: 0033-8230 * |
MUSHTAQ A: "Preparation of high specific-volume solutions of technetium-99m and rhenium-188", APPLIED RADIATION AND ISOTOPES ELSEVIER UK, vol. 58, no. 3, March 2003 (2003-03-01), pages 309 - 314, XP002406011, ISSN: 0969-8043 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102249352A (en) * | 2011-05-23 | 2011-11-23 | 中国工程物理研究院核物理与化学研究所 | Automatic production apparatus for medical pertechnetate |
Also Published As
Publication number | Publication date |
---|---|
EP1870906B1 (en) | 2013-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Meyer et al. | 68 Ga-labelled DOTA-derivatised peptide ligands | |
US10012740B2 (en) | Real time nuclear isotope detection | |
KR101948404B1 (en) | Production of 43sc radionuclide and radiopharmaceuticals thereof for use in positron emission tomography | |
US7737415B2 (en) | System for the control, verification and recording of the performance of a radioisotope generator's operations | |
Knapp Jr et al. | Use of new tandem cation/anion exchange system with clinical-scale generators provides high specific volume solutions of technetium-99m and rhenium-188 | |
Fukumura et al. | An improved 62Zn/62Cu generator based on a cation exchanger and its fully remote-controlled preparation for clinical use | |
Mushtaq | Concentration of 99mTcO4−/188ReO4− by a single, compact, anion exchange cartridge | |
EP1870906B1 (en) | Device for concentrating technetium-99m pertechnetate and method thereof | |
Chattopadhyay et al. | A novel 99mTc delivery system using (n, γ) 99Mo adsorbed on a large alumina column in tandem with Dowex-1 and AgCl columns | |
US20070258885A1 (en) | Device for concentrating Technetium-99m pertechnetate and method thereof | |
Chattopadhyay et al. | A novel technique for the effective concentration of 99mTc from a large alumina column loaded with low specific-activity (n, γ)-produced 99Mo | |
Tatenuma et al. | A mass-production process of a highly pure medical use 99mTc from natural isotopic Mo (n, γ) 99Mo without using uranium | |
Hou | Determination of radionuclidic impurities in 99mTc eluate from 99Mo/99mTc generator for quality control | |
JP4578425B2 (en) | Concentration apparatus and method for technetium-99m pertechnetate solution | |
Fuchigami et al. | Development of a 68Ge/68Ga generator system using polysaccharide polymers and its application in PET imaging of tropical infectious diseases | |
Kao et al. | An efficient and aseptic preparation of “sodium fluoride (18 F) injection” in a GMP compliant facility | |
Budinger et al. | ‘Positron-emission tomography (PET) | |
Thompson et al. | Equipment and instrumentation for radiopharmaceutical chemistry | |
Le et al. | Development of multiple-elution cartridge-based radioisotope concentrator device for increasing the 99m Tc and 188 Re concentration and the effectiveness of 99m Tc/99 Mo utilisation | |
Martini | High-Yield Cyclotron Production of Metallic Radioisotopes for Nuclear Medicine | |
Camroodien | ETD: Development of 18F radiochemistry for positron emission particle tracking (PEPT) | |
Hassanpour et al. | Effect of Eluting the 99 Mo/99 m Tc Generator More than Once in 24 h on the Efficiency of the 99 m Tc-MIBI Complex | |
KR101899848B1 (en) | a continuously medical radioisotope injecting device to the column | |
Tatenuma et al. | Generator of Highly Concentrated Pure 99mTc from Low Specific Activity 99Mo Produced by Reactor and/or Electron Linear Accelerator | |
Choi et al. | The development of a portable MO 4-(M= 188 Re or 99m Tc) concentration device for extending the lifetime of RI generators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060620 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK YU |
|
AKX | Designation fees paid |
Designated state(s): DE FR GB NL |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 602006037795 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: G21G0004000000 Ipc: G21G0001000000 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G21G 4/08 20060101ALI20130213BHEP Ipc: G21G 1/00 20060101AFI20130213BHEP |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): DE FR GB NL |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602006037795 Country of ref document: DE Effective date: 20131010 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 602006037795 Country of ref document: DE Representative=s name: LANGPATENT ANWALTSKANZLEI IP LAW FIRM, DE |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20140515 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602006037795 Country of ref document: DE Effective date: 20140515 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602006037795 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: V1 Effective date: 20150101 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20140620 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602006037795 Country of ref document: DE Effective date: 20150101 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20150227 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140630 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140620 |